HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hui-Ching Wang Selected Research
Hui-Ching Wang Research Topics
Disease
16
Neoplasms (Cancer)
02/2024 - 10/2007
10
Squamous Cell Carcinoma of Head and Neck
02/2024 - 01/2019
7
Infections
04/2022 - 10/2004
5
Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 01/2018
4
Carcinogenesis
02/2023 - 10/2007
4
Neoplasm Metastasis (Metastasis)
12/2022 - 01/2018
4
Hepatocellular Carcinoma (Hepatoma)
06/2010 - 10/2004
3
Adenocarcinoma
01/2022 - 01/2018
3
Rectal Neoplasms (Rectal Cancer)
10/2021 - 08/2019
3
Mouth Neoplasms (Oral Cancer)
09/2021 - 01/2021
3
Chronic Hepatitis B
04/2005 - 12/2003
2
Multiple Myeloma
07/2022 - 10/2016
2
Lymphoma (Lymphomas)
09/2021 - 01/2019
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2021 - 01/2017
2
Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2019
2
Hepatitis B
01/2019 - 08/2006
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 01/2015
2
Retinoblastoma (Glioblastoma, Retinal)
08/2008 - 10/2007
1
Stomach Neoplasms (Stomach Cancer)
02/2024
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2024
1
Head and Neck Neoplasms (Head and Neck Cancer)
02/2023
1
Pathologic Constriction (Stenosis)
01/2023
1
Esophageal Stenosis (Esophageal Stricture)
01/2023
1
Chronic Disease (Chronic Diseases)
10/2022
1
Aspergillosis
10/2022
1
Hematologic Neoplasms (Hematological Malignancy)
10/2022
1
Cytomegalovirus Infections (Inclusion Disease)
04/2022
1
Invasive Fungal Infections
04/2022
1
Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2021
1
Aneuploidy (Aneuploid)
02/2021
1
Extranodal Extension
02/2021
1
Hypopharyngeal Neoplasms
02/2021
1
Lymphatic Metastasis
01/2020
1
Disease Progression
01/2020
1
Microsatellite Instability
08/2019
1
Hepatitis
01/2019
Drug/Important Bio-Agent (IBA)
7
Biomarkers (Surrogate Marker)
IBA
11/2023 - 01/2019
5
Proteins (Proteins, Gene)
FDA Link
02/2024 - 08/2006
5
Surface Antigens (Surface Antigen)
IBA
06/2010 - 12/2003
3
Cetuximab (Erbitux)
FDA Link
02/2024 - 01/2020
3
Gemcitabine
FDA Link
01/2024 - 01/2018
2
Histones (Histone)
IBA
08/2023 - 08/2019
2
Steroids
IBA
01/2023 - 10/2022
2
Messenger RNA (mRNA)
IBA
10/2022 - 11/2004
2
Enzymes
IBA
01/2022 - 02/2021
2
Anthracyclines
IBA
09/2021 - 01/2017
2
Cytokines
IBA
01/2019 - 11/2005
2
Rituximab (Mabthera)
FDA Link
01/2019 - 01/2017
2
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2019 - 10/2004
2
Membrane Proteins (Integral Membrane Proteins)
IBA
04/2005 - 11/2004
1
Neurotensin
IBA
01/2024
1
Peptides (Polypeptides)
IBA
01/2024
1
tributyl phosphate (TBP)
IBA
01/2024
1
Lysine (L-Lysine)
FDA Link
08/2023
1
Histone Methyltransferases
IBA
08/2023
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
02/2023
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2023
1
Receptor-Interacting Protein Serine-Threonine Kinase 2 (CARDIAK)
IBA
01/2023
1
Phenobarbital (Luminal)
FDA Link
01/2023
1
Nucleotides
IBA
01/2023
1
S-Phase Kinase-Associated Proteins (Skp1 Protein)
IBA
12/2022
1
Cadherins (E-Cadherin)
IBA
10/2022
1
galactomannan
IBA
10/2022
1
Catenins
IBA
10/2022
1
Interleukin-8A Receptors (Receptors, Interleukin 8A)
IBA
10/2022
1
Matrix Metalloproteinases (MMPs)
IBA
10/2022
1
CXC Chemokines
IBA
10/2022
1
Proteasome Inhibitors
IBA
07/2022
1
Emodin (Archin)
IBA
07/2022
1
carfilzomib
IBA
07/2022
1
Chromatin
IBA
01/2022
1
RNA (Ribonucleic Acid)
IBA
01/2022
1
Serum Albumin
IBA
09/2021
1
DNA-Directed DNA Polymerase (Polymerases, DNA)
IBA
02/2021
1
Tegafur
IBA
02/2021
1
Uracil
IBA
02/2021
1
Immune Checkpoint Inhibitors
IBA
10/2020
1
Carcinogens
IBA
01/2020
1
Kruppel-Like Factor 4
IBA
01/2020
1
Leucovorin (Folinic Acid)
FDA Link
01/2020
1
Nucleosomes (Nucleosome)
IBA
08/2019
1
Calcibiotic Root Canal Sealer
IBA
08/2019
1
Mi-2 Nucleosome Remodeling and Deacetylase Complex
IBA
08/2019
1
Antigen-Antibody Complex (Immune Complex)
IBA
01/2019
1
Antiviral Agents (Antivirals)
IBA
01/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2019
1
Ligands
IBA
01/2019
1
pembrolizumab
IBA
11/2018
1
Ipilimumab
IBA
11/2018
1
Nivolumab
IBA
11/2018
1
Antibodies
IBA
11/2018
Therapy/Procedure
11
Therapeutics
02/2024 - 10/2016
8
Drug Therapy (Chemotherapy)
01/2024 - 11/2015
6
Chemoradiotherapy
11/2023 - 08/2019
4
Immunotherapy
10/2020 - 11/2018
2
Radiotherapy
12/2022 - 01/2020
1
Hematopoietic Stem Cell Transplantation
04/2022
1
Transplantation
04/2022
1
Adjuvant Chemoradiotherapy
02/2021
1
Proctectomy
08/2019